Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis
Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.
Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.
The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.
- Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
- Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
- Use of checkweighers and sorters
- Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
- Use of quality control labeling systems
It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.
Manufacturing, Packaging & Detailing Industry Research & Market Reports
-
Global Pharmaceutical R & D Directory 2025
The Global Pharmaceutical R&D Directory provides a wealth of key business data on trends in pharmaceutical research. This essential publication is intended as a strategic reference guide to the important trends in pharmaceutical R&D. Read More
-
Anti Microbial Peptides Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
US Active & Intelligent Packaging
... and brand engagement, and a shift in product mix toward higher-value products. This report covers the US market for active and intelligent packaging by product and market. Demand is presented in units and US dollars. ... Read More
-
Pharmaceuticals Markets in China
... has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and ... Read More
-
Pharmaceuticals Industry Forecasts - China Focus
... have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the ... Read More
-
Global Pharmaceutical Excipients Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Biotechnology Product Manufacturing
... the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). COMPETITIVE LANDSCAPE Biotech ... Read More
-
Financial Analysis and Multi-Year Benchmarking: West Pharmaceutical Services Inc (WST:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... forWest Pharmaceutical Services Inc (WST:NYS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for West Pharmaceutical Services Inc (WST:NYS) includes growth forecast for ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amphastar Pharmaceutical Inc (AMPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Pharmaceutical Inc (AMPH:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Amphastar Pharmaceutical Inc (AMPH:NAS) includes growth forecast for its primary industry ... Read More
-
Biological Product Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk & Tariff Analysis & Forecasts
... report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 ... Read More
-
Pharmaceutical Manufacturing - 2025 U.S. Market Research Report with Updated Recession Risk & Tariff Analysis & Forecasts
... is packed with insightful data sets and forecasts to give you a comprehensive understanding of the industry including historical and forecasted industry size, growth, tariff impact analysis, product line breakdown, profitability, financial ratios, 31 balance ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Catalyst Pharmaceutical Inc (CPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Pharmaceutical Inc (CPRX:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Catalyst Pharmaceutical Inc (CPRX:NAS) includes growth forecast for its primary industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Collegium Pharmaceutical Inc (COLL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Pharmaceutical Inc (COLL:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Collegium Pharmaceutical Inc (COLL:NAS) includes growth forecast for its primary industry ... Read More
-
Looking Ahead to 2025 - the Future of Pharma
... analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors. Scope This ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ultragenyx Pharmaceutical Inc (RARE:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
... Pharmaceutical Inc (RARE:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Ultragenyx Pharmaceutical Inc (RARE:NAS) includes growth forecast for its primary industry ... Read More
-
Pharmaceutical Sterility Testing Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
TNF Alpha Inhibitors Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Global Ibuprofen Active Pharmaceutical Ingredient (API) Market 2025-2029
... report on the ibuprofen active pharmaceutical ingredient (API) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Pharmaceutical Packaging Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... in pharmaceutical manufacturing, increasing demand for tamper-evident and traceable packaging, and the global rise in chronic disease incidence. Pharmaceutical packaging plays a critical role in ensuring drug safety, maintaining product integrity, and facilitating regulatory compliance. ... Read More
-
Contract Research Organization Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
... across pharmaceutical, biotechnology, and medical device sectors, alongside the rising complexity of clinical trials and personalized medicine demands. The widespread outsourcing of research activities to contract research organizations (CROs) allows companies to focus on core ... Read More
-
U.S. Pharmaceutical Stability and Storage Services Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
... demand for temperature-controlled storage solutions, increasing regulatory requirements for drug stability testing, and the growing development of biologics and specialty pharmaceuticals. Pharmaceutical stability storage services play a vital role in ensuring the safety, efficacy, and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
... will save countless hours of research. Key Findings: Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.) to reach $312,882,043,584 by 2031. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
... will save countless hours of research. Key Findings: Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.) to reach $387,074,915,562 by 2031. Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210
... save countless hours of research. Key Findings: Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.) to reach $1,803,334,325,954 by 2031. Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.), including Average EBITDA, Operating Ratios and Sales per Employee. ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200
... will save countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $1,803,334,325,954 by 2031. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.), including Average EBITDA, Operating Ratios and ... Read More